Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
View all What we do
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Cirrhosis in over 16s: assessment and management

NICE guideline
Reference number: NG50
Published: 06 July 2016
Last updated: 08 September 2023

History

Guidance published

Consultation comments and responses (PDF 367 KB)

Published:

08 September 2023
Committee member list (PDF 146 KB)

Published:

08 September 2023
Equality impact assessment (PDF 142 KB)

Published:

08 September 2023

Declaration of interests

Register of interests (PDF 261 KB)

Published:

24 August 2023

Draft guidance consultation

Draft guidance consultation
Draft guideline (PDF 348 KB)

Published:

16 May 2023
Evidence review A (PDF 2.59 MB)

Published:

16 May 2023
Evidence review B (PDF 1.09 MB)

Published:

16 May 2023
Evidence review C (PDF 1.25 MB)

Published:

16 May 2023
Committee member list (PDF 148 KB)

Published:

16 May 2023
Supporting evidence Interests Register (PDF 261 KB)

Published:

16 May 2023
Supporting evidence Methods (PDF 314 KB)

Published:

16 May 2023
Comments form (MSWord 41 KB)

Published:

16 May 2023
Equality impact assessment (PDF 189 KB)

Published:

16 May 2023

Pre-consultation documents released

Economic plan (PDF 117 KB)

Published:

11 April 2023
Review questions (PDF 152 KB)

Published:

11 April 2023
Equality impact assessment (PDF 189 KB)

Published:

16 May 2023

Committee list updated

Committee member list (PDF 146 KB)

Published:

01 February 2023

Committee meetings

Committee meeting: 1
Minutes (PDF 241 KB)

Published:

10 February 2023
Committee meeting: 2
Minutes (PDF 202 KB)

Published:

20 March 2023
Committee meeting: 3
Minutes (PDF 210 KB)

Published:

24 August 2023

Scope published

Consultation comments and responses (PDF 268 KB)

Published:

09 December 2022
Equality impact assessment (PDF 193 KB)

Published:

09 December 2022
Final scope (PDF 196 KB)

Published:

09 December 2022

Draft scope consultation

Draft scope consultation
Equality impact assessment (PDF 204 KB)

Published:

04 October 2022
Comments form (MSWord 35 KB)

Published:

04 October 2022
Draft scope (PDF 177 KB)

Published:

04 October 2022

Stakeholder list updated

Stakeholder list (PDF 114 KB)

Published:

03 October 2022

Original development on 06 July 2016

Surveillance consultation
Surveillance consultation
Surveillance review proposal (PDF 1.38 MB)

Published:

27 July 2020
Comments form (MSWord 30 KB)

Published:

27 July 2020
Stakeholder list updated
Stakeholder list (PDF 112 KB)

Published:

23 July 2020
Equality and health inequalities assessment
Equality impact assessment (PDF 216 KB)

Published:

06 July 2016
Committee list updated
Committee member list (PDF 308 KB)

Published:

06 July 2016
Consultation comments published
Consultation comments and responses (PDF 627 KB)

Published:

06 July 2016
Stakeholder list updated
Stakeholder list (PDF 42 KB)

Published:

05 July 2016
Equality and health inequalities assessment
Equality impact assessment (PDF 201 KB)

Published:

18 April 2016
Stakeholder list updated
Stakeholder list (PDF 41 KB)

Published:

09 March 2016
Draft guidance consultation
Draft guidance consultation
Full guideline updated (PDF 3.06 MB)

Published:

18 December 2015
Short version of draft guideline (PDF 268 KB)

Published:

18 December 2015
Addendum appendicies (PDF 8.13 MB)

Published:

18 December 2015
Stakeholder list (PDF 40 KB)

Published:

18 December 2015
Comments form (MSWord 37 KB)

Published:

18 December 2015
Confidentiality form (MSWord 28 KB)

Published:

18 December 2015
Equality impact assessment Section 3 (PDF 251 KB)

Published:

04 April 2016
Review questions document published
Review questions (PDF 12 KB)

Published:

02 November 2015
Review questions document published
Economic plan (PDF 96 KB)

Published:

21 October 2015
Review questions (PDF 12 KB)

Published:

21 October 2015
Search strategies (PDF 729 KB)

Published:

21 October 2015
Committee meeting: 9
Minutes (PDF 283 KB)

Published:

03 February 2016
Committee meeting: 10
Minutes (PDF 351 KB)

Published:

03 February 2016
Committee meeting: 11
Minutes (PDF 113 KB)

Published:

01 June 2016
Committee meeting: 12
Minutes (PDF 88 KB)

Published:

01 June 2016
Gdg minutes
Gdg minutes
GDG member list (PDF 180 KB)

Published:

20 October 2014
Gdg 1 minutes (PDF 236 KB)

Published:

16 December 2014
Gdg 2 minutes (PDF 149 KB)

Published:

16 December 2014
Gdg 3 minutes (PDF 311 KB)

Published:

14 July 2015
Gdg 4 minutes (PDF 242 KB)

Published:

14 July 2015
Gdg 5 minutes (PDF 335 KB)

Published:

14 July 2015
Gdg 6 minutes (PDF 269 KB)

Published:

14 July 2015
Gdg 7 minutes (PDF 374 KB)

Published:

14 July 2015
Gdg 8 minutes (PDF 383 KB)

Published:

14 July 2015
Final scope
Final scope (PDF 167 KB)

Published:

16 July 2014
Scoping consultation
Scoping consultation information
Equality impact assessment - scoping (PDF 136 KB)

Published:

20 July 2015
Stakeholder comments (PDF 625 KB)

Published:

20 October 2014
Draft scope (PDF 168 KB)

Published:

14 April 2014
Stakeholder list (PDF 21 KB)

Published:

14 April 2014